Aspirin for reducing cancer metastases?

Area of Science:

• Oncology
• Hematology

Background:

• Distant metastases are the primary cause of cancer-related mortality.
• Animal studies demonstrate that anticoagulants and fibrinolytic agents significantly reduce metastases.

Purpose of the Study:

• To evaluate the potential of aspirin in preventing cancer metastases in human patients.
• To explore aspirin's mechanism of action in reducing cancer spread.

Main Methods:

• Review of existing animal and human studies on anticoagulants, fibrinolytic agents, and aspirin.
• Analysis of aspirin's known effects on platelet function and fibrinolysis in humans.

Main Results:

• Aspirin inhibits platelet aggregation.
• Aspirin enhances the body's natural clot-dissolving (fibrinolytic) activity.
• These mechanisms suggest a potential role in reducing cancer metastasis.

Conclusions:

• Aspirin may be an effective option for reducing distant metastases in cancer patients.
• Further clinical investigation is warranted to confirm aspirin's efficacy in cancer metastasis prevention.